Зарегистрируйтесь на getAbstract, чтобы получить доступ к этому краткому изложению.

The Trip Treatment

Зарегистрируйтесь на getAbstract, чтобы получить доступ к этому краткому изложению.

The Trip Treatment

Research into psychedelics, shut down for decades, is now yielding exciting results.

The New Yorker,

5 мин на чтение
5 основных идей
Аудио и текст

Что внутри?

Research into psychedelics shows promising results for cancer patients with anxiety, but is it safe?

автоматическое преобразование текста в аудио
  • 0.5×
  • 0.75×
  • 1×
  • 1.25×
  • 1.5×
  • 1.75×
1×
автоматическое преобразование текста в аудио

Editorial Rating

8

Qualities

  • Controversial
  • Scientific
  • Engaging

Recommendation

Journalist Michael Pollan explains the fascinating history of medical research into psychedelics and captures the sense of wonder among researchers and patients experimenting with them today. It’s hard not to be amazed by Pollan’s accounts of mystical, life-changing experiences – especially among patients facing death. The findings from patients’ brain scans also make intriguing reading. getAbstract recommends this article to anyone who wants to know exactly how the brain creates mystical experiences, either drug-induced or otherwise.

Summary

In 1953, the first government-funded medical research into psychedelics took place in the United States. Over the next 20 years, researchers used lysergic acid diethylamide (LSD) in more than 1,700 patients, including addicts, those with terminal cancer and the mentally ill. The findings were encouraging, but the studies were often poorly conceived or executed. When then US president Richard Nixon outlawed psychedelics in 1970, the studies ceased and the field of psychiatry moved on.

In 2006, respected drug addiction researcher Roland Griffiths...

About the Author

Michael Pollan teaches journalism at the University of California, Berkeley.

Comment on this summary